Wells Fargo lowered the firm’s price target on Ryan Specialty (RYAN) to $64 from $68 and keeps an Equal Weight rating on the shares. Discussing the insurance industry, Wells notes that for non-life insurance, the focus remains on cats, pricing, loss trend, reserves and margins. Domestically Q4 cats are above normal due to Milton, with international losses from Spanish floods. For Life insurance, the focus is on sales growth, rate commentary, Group results, and guides. Sales growth should continue to get attention, while group results are trending well, and life companies continue to return capital. Meanwhile, Brokers should continue to see good organic growth, the firm adds.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $77 from $79 at Keefe Bruyette
- Ryan Specialty buys Velocity Risk underwriters from Oaktree for $525M
- Ryan Specialty initiated with an Overweight at Morgan Stanley
- Ryan Specialty Group Announces $500M Senior Notes Offering
- Ryan Specialty price target raised to $88 from $76 at Barclays